Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France

Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France

<p>Abstract</p> <p>Background</p> <p>Five diseases are currently screened on dried blood spots in France through the national newborn screening programme. Tandem mass spectrometry (MS/MS) is a technology that is increasingly used to screen newborns for an increasing num...

Full description

Bibliographic Details
Main Authors: Hamers Françoise F, Rumeau-Pichon Catherine
Format: Article
Language:English
Published: BMC 2012-06-01
Series:BMC Pediatrics
Subjects:
Medium-chain Acyl-CoA dehydrogenase deficiency
Cost effectiveness
Neonatal screening
Health policy
Tandem mass spectrometry
France
Online Access:http://www.biomedcentral.com/1471-2431/12/60

Internet

http://www.biomedcentral.com/1471-2431/12/60

Similar Items